Virtual Medical Consilium (VMC) provides scientifically sound and evidence-based clinical advice to national TB expert committee or technical working group and individual practitioners on the management of DR-TB and other difficult-to-treat TB cases in the WHO European Region.
For information
Since establishment on 01.10.2020 and up to 28.11.2024, VMC consulted 440 people with TB from 13 countries.
Read the instructions
Read the instructions here.
Submit a request for advice
Submit completed Case Presentation Form to eurotbvmc@who.int. It is important to make sure that all submitted documents do not contain patient personal data.
Members of Virtual Medical Consilium will review your request
When needed, the Coordinator of VMC may request additional information.
Conclusion and recomendations
Decision will be sent in response to your e-mail letter. We usually reply within 48 hours (excluding Saturday and Sunday).
How to get a VMC consultation?
Instructions for presentation of clinical cases to VMC:
What are the advantages of VMC?
The VMC reviews each individual situation on a case-by-case basis taking into consideration the current medical condition of the patient, past medical history, drug-resistance profile, data from vital, laboratory and instrumental examinations, availability of drugs in the country, and other available information, as well as the latest WHO guidance on medical management of DR-TB and international experience. In circumstances related to treatment performed within operational research (mSTRs, BPaL), the Consilium will refer to conditions of operational research protocol approved by the national/local ethics review committee of specific country. All consultations are provided for free.
2025 update of the WHO DR-TB guidelines
Joint Meeting of the WHO BPaLM Accelerator Platform and EuroVMC
TB in children and adolescents 2024
